All Relations between von Hippel-Lindau Disease and alpha
| Publication | Sentence | Publish Date | Extraction Date | Species |
|---|---|---|---|---|
| Farzad Jamshidi, Lola Lozano, Budd Tucker, Jean Andorf, Elliott Sohn, Edwin Stone, Andrew Groves, Yousef Zakharia, H Culver Boldt, Elaine Binkle. Belzutifan in Individuals with von Hippel-Lindau Retinal Hemangioblastomas: Institutional Experience and Review of the Literature. Ocular oncology and pathology. vol 10. issue 3. 2024-09-03. PMID:39224523. | the systemic hif-2 alpha inhibitor, belzutifan, has been approved for use in patients with von hippel-lindau disease (vhl)-associated renal cell carcinoma, central nervous system (cns) hemangioblastomas, and pancreatic neuroendocrine tumors. | 2024-09-03 | 2024-09-05 | Not clear |
| Akiko Miyazawa, Makoto Inoue, Akito Hirakata, Annabelle A Okada, Kuniko Iihara, Yasunori Fujiok. Expression of inhibin alpha by stromal cells of retinal angiomas excised from a patient with von Hippel-Lindau disease. Japanese journal of ophthalmology. vol 53. issue 5. 2009-12-07. PMID:19847606. | expression of inhibin alpha by stromal cells of retinal angiomas excised from a patient with von hippel-lindau disease. | 2009-12-07 | 2023-08-12 | Not clear |